Fatal Acinetobacter baumannii Infection with Discordant Carbapenem Susceptibility
Open Access
- 1 September 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (5) , 758-759
- https://doi.org/10.1086/432623
Abstract
Potential conflicts of interest. All authors: no conflicts.Keywords
This publication has 5 references indexed in Scilit:
- Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999–2003)Diagnostic Microbiology and Infectious Disease, 2004
- Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North AmericaDiagnostic Microbiology and Infectious Disease, 2003
- Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Meta-analysis of the clinical outcome of carbapenem monotherapy in the adjunctive treatment of intra-abdominal infections.The American Journal of Surgery, 1997
- Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patientsJournal of Antimicrobial Chemotherapy, 1996